PARTNERVETAS - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,213,460 | 976,568 | 1,095,839 | 1,073,995 | 1,096,443 | 1,253,247 | 1,294,194 | 1,667,981 |
| Profit before tax | -474 | -13,241 | 26,969 | 6,569 | 10,149 | 32,594 | -3,699 | 11,131 |
| Net profit | -1,167 | -13,241 | 24,410 | 5,172 | 7,831 | 26,523 | -4,886 | 8,035 |
| Equity | 26,464 | 13,223 | 37,633 | 42,805 | 50,636 | 77,159 | 73,460 | 91,836 |
| Liabilities | 400,532 | 343,469 | 324,794 | 308,815 | 372,182 | 349,447 | 386,387 | 360,023 |
| Non-current assets | 15,631 | 5,711 | 15,600 | 11,265 | 12,929 | 10,095 | 30,980 | 54,635 |
| Current assets | 410,698 | 348,755 | 345,625 | 340,024 | 410,804 | 415,415 | 426,249 | 395,127 |
| Total assets | 426,329 | 354,466 | 361,225 | 351,289 | 423,733 | 425,510 | 457,229 | 449,762 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 258,467 | 281,614 | 281,350 |
| Social insurance contributions | - | - | - | - | - | 46,326 | 49,711 | 57,098 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +3.2% | -19.5% | +12.2% | -2.0% | +2.1% | +14.3% | +3.3% | +28.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -0.3% | -3.7% | 6.8% | 1.5% | 1.8% | 6.2% | -1.1% | 1.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -4.4% | -100.1% | 64.9% | 12.1% | 15.5% | 34.4% | -6.7% | 8.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -0.1% | -1.4% | 2.2% | 0.5% | 0.7% | 2.1% | -0.4% | 0.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 0.0% | -1.4% | 2.5% | 0.6% | 0.9% | 2.6% | -0.3% | 0.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 15.1 | 26.0 | 8.6 | 7.2 | 7.4 | 4.5 | 5.3 | 3.9 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 142,760 | 139,510 | 156,548 | 153,428 | 156,635 | 176,930 | 161,774 | 212,935 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
PARTNERVETAS - Social security debts
The company had no debts to Sodra
PARTNERVETAS - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
PARTNERVETAS, UAB (code 302583024) is a private limited liability company engaged in the wholesale of pharmaceutical and medical goods. In 2025, revenue increased to €1.67M, up 28.9% year on year and 33.1% over two years. Net profit returned to €8.0K after a €4.9K loss in 2024, while 2023 net profit was €26.5K. Profit margin improved to 0.5% in 2025 from -0.4% in 2024 and 2.1% in 2023. Total assets stood at €449.8K at the end of 2025, with equity of €91.8K and liabilities of €360.0K, resulting in an equity ratio of 20.4% and debt-to-equity of 3.92. Long-term assets rose to €54.6K from €31.0K in 2024, while short-term assets were €395.1K. Return on equity was 8.8% and return on assets 1.8%. Revenue per employee was €238.3K and profit per employee €1.1K.